Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by WM. Tai
The Novel ATM Inhibitor (AZ31) Enhances Antitumor Activity in Patient Derived Xenografts That Are Resistant to Irinotecan Monotherapy
Oncotarget
Oncology
Related publications
Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation by Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-Resistant Tumor Xenografts
Oncology Reports
Medicine
Cancer Research
Oncology
Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, Against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET
International Journal of Cancer
Cancer Research
Oncology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
Antitumor Activity of Sorafenib Plus CDK4/6 Inhibitor in Pancreatic Patient Derived Cell With KRAS Mutation
Journal of Cancer
Oncology
Factors That Influence Response Classifications in Chemotherapy Treated Patient-Derived Xenografts (PDX)
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
A Novel YAP1 Inhibitor Targets CSCs-enriched Radiation Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Establishment of Patient-Derived Xenografts in Mice
BIO-PROTOCOL
P1.13-05 Integrin Β3 Inhibition Enhances the Antitumor Activity of Alk Inhibitor in Alkrearranged NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701
Cancer Science
Cancer Research
Medicine
Oncology
